[go: up one dir, main page]

MX9102612A - Derivados de trifluorometilcetona, procedimiento para la preparacion del mismo y uso del mismo. - Google Patents

Derivados de trifluorometilcetona, procedimiento para la preparacion del mismo y uso del mismo.

Info

Publication number
MX9102612A
MX9102612A MX9102612A MX9102612A MX9102612A MX 9102612 A MX9102612 A MX 9102612A MX 9102612 A MX9102612 A MX 9102612A MX 9102612 A MX9102612 A MX 9102612A MX 9102612 A MX9102612 A MX 9102612A
Authority
MX
Mexico
Prior art keywords
same
alkyl
preparation
derivatives
trifluorome
Prior art date
Application number
MX9102612A
Other languages
English (en)
Inventor
Keiji Hemmi
Ichiro Shima
Keisuke Imai
Hirokazu Tanaka
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909028231A external-priority patent/GB9028231D0/en
Priority claimed from GB919119713A external-priority patent/GB9119713D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of MX9102612A publication Critical patent/MX9102612A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06191Dipeptides containing heteroatoms different from O, S, or N
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
  • Magnetically Actuated Valves (AREA)
  • Control Of Throttle Valves Provided In The Intake System Or In The Exhaust System (AREA)
MX9102612A 1990-12-31 1991-12-17 Derivados de trifluorometilcetona, procedimiento para la preparacion del mismo y uso del mismo. MX9102612A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909028231A GB9028231D0 (en) 1990-12-31 1990-12-31 Trifluoromethylketone derivatives,processes for preparation thereof and use thereof
GB919119713A GB9119713D0 (en) 1991-09-16 1991-09-16 Trifluoremethylketone derivatives, processes for preparation thereof and use thereof

Publications (1)

Publication Number Publication Date
MX9102612A true MX9102612A (es) 1992-06-01

Family

ID=26298196

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9102612A MX9102612A (es) 1990-12-31 1991-12-17 Derivados de trifluorometilcetona, procedimiento para la preparacion del mismo y uso del mismo.

Country Status (19)

Country Link
US (2) US5296591A (es)
EP (1) EP0494071B1 (es)
JP (1) JPH0699378B2 (es)
KR (1) KR100192991B1 (es)
CN (1) CN1040003C (es)
AT (1) ATE151775T1 (es)
AU (1) AU641577B2 (es)
CA (1) CA2058560C (es)
DE (1) DE69218977T2 (es)
DK (1) DK0494071T3 (es)
ES (1) ES2099755T3 (es)
FI (1) FI106379B (es)
GR (1) GR3023719T3 (es)
HU (2) HU210263B (es)
IE (1) IE914360A1 (es)
MX (1) MX9102612A (es)
NO (1) NO309274B1 (es)
RU (1) RU2073684C1 (es)
SG (1) SG50457A1 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5296591A (en) * 1990-12-31 1994-03-22 Fujisawa Pharmaceutical Co., Ltd. Trifluoromethylketone derivatives, processes for preparation thereof and use thereof
US5478811A (en) * 1991-08-22 1995-12-26 Merrell Dow Pharmaceuticals Inc. Orally-active elastase inhibitors
US5714470A (en) * 1991-08-22 1998-02-03 Merrell Pharmaceuticals, Inc. Orally-active elastase inhibitors
FR2694295B1 (fr) * 1992-07-28 1994-09-02 Adir Nouveaux peptides dérivés de trifluoromethylcetones, leur procéde de préparation et les compositions pharmaceutiques qui les contiennent.
FR2719589B1 (fr) * 1994-05-05 1996-06-14 Adir Nouveaux peptides dérivés de trifluorométhylcétones, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
DE69513167T2 (de) * 1994-06-02 2000-06-15 Merrell Pharmaceuticals Inc., Cincinnati Perfluoroalkyll ketone, inhibitoren von elastase und prozess zur deren herstellung
AU696292B2 (en) * 1994-06-02 1998-09-03 Merrell Pharmaceuticals Inc. Acylated enol derivatives as prodrugs of elastase inhibitors
US6172044B1 (en) 1995-12-01 2001-01-09 Aventis Pharmaceuticals Inc. Acylated enol derivative of α-ketoesters and α-ketoamides
US5948886A (en) * 1996-11-20 1999-09-07 Hoechst Marion Roussel, Inc. Acylated enol derivatives of α-ketoesters and α-ketoamides
JP2002161051A (ja) * 1996-12-24 2002-06-04 Fujisawa Pharmaceut Co Ltd 脳虚血性疾患等の治療剤
US6610748B1 (en) * 1998-02-24 2003-08-26 Fujisawa Pharmaceutical Co., Ltd. Preventives/remedies for skin aging
US20020045231A1 (en) * 1999-02-02 2002-04-18 Napper Andrew D. Catalytic antibodies which hydrolyze primary amides and methods for eliciting such antibodies
EP1230933A4 (en) * 1999-10-12 2004-01-02 Fujisawa Pharmaceutical Co MEDICINE FOR NARROWED Wounds
IL148924A (en) * 2002-03-26 2015-06-30 Mor Research Applic Ltd Use of substances that inhibit intracellular elastase activity in the preparation of a drug for the treatment and / or prevention of necrosis of cells and related diseases
DE10219464A1 (de) 2002-04-30 2003-11-13 Focke & Co Zigarettenpackung
SE0202462D0 (sv) * 2002-08-14 2002-08-14 Astrazeneca Ab Novel use
WO2007140117A1 (en) * 2006-05-23 2007-12-06 Irm Llc Compounds and compositions as channel activating protease inhibitors
WO2008023446A1 (fr) * 2006-08-25 2008-02-28 Stelic Institute Of Regenerative Medicine, Stelic Institute & Co. Remède pour des bronchopneumopathies chroniques obstructives
CA2669917A1 (en) * 2006-11-17 2008-05-22 Dawn M. George Aminopyrrolidines as chemokine receptor antagonists
AU2010307006B2 (en) 2009-10-13 2016-08-11 Ligand Pharmaceuticals Inc. Hematopoietic growth factor mimetic small molecule compounds and their uses
ES2645847T3 (es) * 2013-05-08 2017-12-11 Kissei Pharmaceutical Co., Ltd. Derivado de glicinamida alfa-sustituido
CN104650016A (zh) * 2015-01-29 2015-05-27 武汉大学 拟三肽类化合物及其制备方法
CA3026270C (en) * 2016-06-24 2024-06-18 Pola Chemical Industries, Inc. External preparation for skin for wrinkle improvement
US20200368131A1 (en) 2017-11-15 2020-11-26 Pola Chemical Industries, Inc. Oil-based composition
CN119241385A (zh) * 2024-11-29 2025-01-03 江西师范大学 β-酰氧基烯酰胺衍生物及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8600263D0 (en) 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives
EP0276101A3 (en) * 1987-01-19 1989-11-23 Ici Americas Inc. Substituted peptide derivatives
EP0369391A3 (en) * 1988-11-15 1991-09-25 Boehringer Ingelheim Pharmaceuticals Inc. N-substituted amides
US5221665A (en) * 1989-10-27 1993-06-22 Boehringer Ingelheim Pharmaceuticals, Inc. N-substituted amides
US5296591A (en) * 1990-12-31 1994-03-22 Fujisawa Pharmaceutical Co., Ltd. Trifluoromethylketone derivatives, processes for preparation thereof and use thereof

Also Published As

Publication number Publication date
CN1040003C (zh) 1998-09-30
NO309274B1 (no) 2001-01-08
JPH0699378B2 (ja) 1994-12-07
HU210263B (en) 1995-03-28
SG50457A1 (en) 1998-07-20
HUT60507A (en) 1992-09-28
CA2058560C (en) 2000-12-12
HU914153D0 (en) 1992-03-30
AU8985391A (en) 1992-07-02
NO920035D0 (no) 1992-01-02
AU641577B2 (en) 1993-09-23
FI106379B (fi) 2001-01-31
FI915996A (fi) 1992-07-01
HU211943A9 (en) 1996-01-29
US5430025A (en) 1995-07-04
DE69218977D1 (de) 1997-05-22
GR3023719T3 (en) 1997-09-30
EP0494071A2 (en) 1992-07-08
RU2073684C1 (ru) 1997-02-20
KR920011988A (ko) 1992-07-25
IE914360A1 (en) 1992-07-01
CN1063108A (zh) 1992-07-29
FI915996A0 (fi) 1991-12-19
KR100192991B1 (ko) 1999-06-15
DE69218977T2 (de) 1997-08-07
CA2058560A1 (en) 1992-07-01
EP0494071A3 (en) 1993-05-05
ES2099755T3 (es) 1997-06-01
EP0494071B1 (en) 1997-04-16
ATE151775T1 (de) 1997-05-15
JPH04297446A (ja) 1992-10-21
US5296591A (en) 1994-03-22
DK0494071T3 (es) 1997-05-12
NO920035L (no) 1992-07-01

Similar Documents

Publication Publication Date Title
MX9102612A (es) Derivados de trifluorometilcetona, procedimiento para la preparacion del mismo y uso del mismo.
ATE161836T1 (de) 4-substituierte-2-deoxy-2,3-didehydro alpha-d- neuraminsäure antivirale derivate
BR9713884A (pt) Benzamida heterociclicamente substituìda, usos da mesma e de cetobenzamidoaldeìdos desta, e, preparação medicamentosa.
DE59010536D1 (de) Diphenylheteroalkylderivate, ihre Herstellung und daraus hergestellte Arzneimittel und Kosmetika
ES2091359T3 (es) Nuevo compuesto peptidico y un procedimiento para su preparacion.
ES2160602T3 (es) Derivados de quinolona y acridinona para el tratamiento de la incontinencia urinaria.
DK581889A (da) Antiatherosclerotiske diarylforbindelser
MX9202544A (es) Compuestos de diaminoftalimidas substituidas y analogas, procedimiento para su preparacion y preparados farmaceuticos que los contienen.
IL106445A0 (en) 4-substituted 1,2,4-triazole derivatives,their preparation and pharmaceutical compositions containing them
ATE170852T1 (de) Benzolsulfonamid-derivate zur behandlung der blaseninstabilität
ES2117013T3 (es) Derivado de difenilpiperazina y medicamento para organos del aparato circulatorio que contiene este compuesto.
FI935800A0 (fi) Antidepressiva och mot Parkisons sjukdom verksamma foereningar
DE69330601D1 (de) Serotoninergische ergolin derivate
PT855398E (pt) Derivados sasquiterpeno tendo actividade antiviral
NO923983L (no) Bisfenyletanderivater, fremgangsmaate for deres fremstilling og farmasoeytiske preparater derav
FR2572074B1 (fr) Derives du thiadiazole actifs sur le systeme nerveux central, procede d'obtention et compositions pharmaceutiques les contenant
SE9203824L (sv) Bensofuranylimidazol-derivat, foerfarande foer framstaellning daerav och terapeutiska kompositioner innehaallande desamma
SE8903313L (sv) Nya 2-metoxikarbonyl-substituerade n,n'-di-(trimetoxibensoyl)-piperaziner, foerfarande foer framstaellning daerav och terapeutiska foereningar innehaallande dem
DE3169918D1 (en) Cis-c3",c4"-carbonate derivatives of oleandomycin-y, pharmaceutical compositions containing them, and intermediates therefor
FI955142A0 (fi) Bentso(f)kinoksaliinidionijohdannaisia, niiden valmistus ja käyttö lääkkeinä
FR2781482B1 (fr) Nouveaux derives de 8h-thieno-[2,3-b]pyrrolizine-8-one, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FI911616A (fi) Substituerade 3-tia- eller 3-oxa-alkyl -flavoner, foerfarande foer deras framstaellning, deras anvaendning, pao dessa foereningar baserade laekemedel samt mellanprodukter.